CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Lotrafilcon B contact lens (AIR OPTIX® AQUA) +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01300741
NCT01300741N/ACompleted

One Month Performance Comparison Between 2 Commercially Available Silicone Hydrogel Lenses

CIBA VISION·interventional·Posted Feb 23, 2011·Updated Jul 10, 2012

In Brief

A clinical study evaluating Lotrafilcon B contact lens (AIR OPTIX® AQUA), Galyfilcon A contact lens (ACUVUE® ADVANCE® Plus), and 1 other intervention for Myopia. Completed, enrolled 75 participants.

Detailed Summary

The purpose of this study is to compare the performance of two commercially marketed contact lenses when worn for up to one month in a daily wear modality.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 23, 2011
Enrollment StartFeb 1, 2011
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.4 years ago

Interventions

Lotrafilcon B contact lens (AIR OPTIX® AQUA)device

Silicone hydrogel, single vision contact lens worn in one eye in a daily wear modality for approximately 5 days or more per week, at least 10 hours per day, for up to 4 weeks.

Galyfilcon A contact lens (ACUVUE® ADVANCE® Plus)device

Silicone hydrogel, single vision contact lens worn in one eye in a daily wear modality for approximately 5 days or more per week, at least 10 hours per day, for up to 4 weeks.

Contact lens solution (Clear Care®)device

Hydrogen peroxide-based system used for cleaning, disinfection and overnight storage of the study contact lenses.